cinnamates - CISMeF

Preferred Label : cinnamates;

MeSH definition : Derivatives of cinnamic acid (the structural formula: phenyl-HC CH-COO-), including its salts and esters.;

MeSH synonym : Cinnamate;

Is substance : O;

Détails

Origin ID

D002934;

UMLS CUI

C0008801;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- cinnamates [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2-(1-diethylaminoacetoxy)pentyl)benzoic acid (2-methoxy-4-(2-(4-nitrooxybutoxycarbonyl)vinyl))phenyl ester [MeSH Supplementary Concept]
- (2R,3S)-pinobaksin-3-cinnamate [MeSH Supplementary Concept]
- (2R,3S)-pinobanksin-3-cinnamate [MeSH Supplementary Concept]
- (4-(dimethylamino)cinnamoyl)imidazole [MeSH Supplementary Concept]
- (E)-cinnamyl cinnamate [MeSH Supplementary Concept]
- (E)-docosyl-3,4-dihydroxycinnamate [MeSH Supplementary Concept]
- (N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine) [MeSH Supplementary Concept]
- (Z,R)-1-phenylethylcinnamate [MeSH Supplementary Concept]
- 1,1-dimethylallyl-3',4'-dihydroxycinnamic acid ester [MeSH Supplementary Concept]
- 1,3-di-O-cinnamoyl-glycerol [MeSH Supplementary Concept]
- 1-(3-(3,4,5-trimethoxyphenyl)acryloyl)piperidin-2-one [MeSH Supplementary Concept]
- 1-(5,8-dihydro-1,4-dihydroxy-5,8-dioxo-2-naphthyl)-4-methylpent-3-en-1-yl cinnamate [MeSH Supplementary Concept]
- 1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-enyl-3-(3-(trifluoromethyl)phenyl)acrylate [MeSH Supplementary Concept]
- 1-O-cis-cinnamoyl-beta-D-glucopyranose [MeSH Supplementary Concept]
- 1-O-trans-cinnamoyl-beta-D-glucopyranose [MeSH Supplementary Concept]
- 1-methylimidazolium alpha-cyano-4-hydroxycinnamate [MeSH Supplementary Concept]
- 11alpha-dihydroxy-3beta-cinnamoyl-alpha-amyrin [MeSH Supplementary Concept]
- 2'-benzoxycinnamaldehyde [MeSH Supplementary Concept]
- 2,3-di-O-isoferuloyltartaric acid [MeSH Supplementary Concept]
- 2,3-dihydroxycinnamic acid [MeSH Supplementary Concept]
- 2,3-dimethoxycinnamoyl azide [MeSH Supplementary Concept]
- 2,4,5-trimethoxycinnamic acid [MeSH Supplementary Concept]
- 2,4-dichlorocinnamic acid [MeSH Supplementary Concept]
- 2,4-dichlorocinnamic acid hydroxamate [MeSH Supplementary Concept]
- 2,7,10-triacetoxy-5-cinnamyloxy-9-hydroxy-taxa-4(20),11-diene-13-one [MeSH Supplementary Concept]
- 2-(2'-O-trans-cinnamoyl)-C-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone [MeSH Supplementary Concept]
- 2-(3-(3,4-dimethoxyphenyl)prop-2-enamido)ethyltriphenylphosphonium [MeSH Supplementary Concept]
- 2-(4-acetylanilino)-2-oxoethyl cinnamate [MeSH Supplementary Concept]
- 2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid [MeSH Supplementary Concept]
- 2-(4-imidazoyl)hydrocinnamic acid [MeSH Supplementary Concept]
- 2-(5-((4-methoxy-2-(trifluoromethyl)quinolin-6-yl)methoxy)-2-((4-(trifluoromethyl)benzyl)oxy)benzylidene)hexanoic acid [MeSH Supplementary Concept]
- 2-(trans-cinnamoyloxy-methyl)-1-butene-4-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 2-O-caffeoyl-3-O-isoferuloyltartaric acid [MeSH Supplementary Concept]
- 2-chlorocinnamic acid [MeSH Supplementary Concept]
- 2-ethoxycinnamic acid [MeSH Supplementary Concept]
- 2-ethylhexyl 2,4,5-trimethoxycinnamate [MeSH Supplementary Concept]
- 2-fluoro-p-hydroxycinnamate [MeSH Supplementary Concept]
- 2-fluorocinnamic acid [MeSH Supplementary Concept]
- 2-glucosyloxycinnamic acid [MeSH Supplementary Concept]
- 2-methylphenyl 4-ethoxycinnamate [MeSH Supplementary Concept]
- 2-methylphenyl 4-methoxycinnamate [MeSH Supplementary Concept]
- 2-methylphenyl cinnamate [MeSH Supplementary Concept]
- 24-dihydrocycloeucalenol-3-(Z)-p-hydroxycinnamate [MeSH Supplementary Concept]
- 3'-O-(8''-Z-caffeoyl)rosmarinic acid [MeSH Supplementary Concept]
- 3'-O-beta-D-glucopyranosyl rosmarinic acid [MeSH Supplementary Concept]
- 3'-methoxycinnamic acid-4'-sulfate [MeSH Supplementary Concept]
- 3,4,5-trihydroxycinnamic acid [MeSH Supplementary Concept]
- 3,4,5-trimethoxycinnamic acid [MeSH Supplementary Concept]
- 3,4-di(OH)-cinnamate [MeSH Supplementary Concept]
- 3,4-diacetoxycinnamic acid [MeSH Supplementary Concept]
- 3,4-dihydroxyhydrocinammic acid (L-alanine methyl ester) amide [MeSH Supplementary Concept]
- 3,4-dihydroxyhydrocinammic acid (l-aspartic acid dibenzyl ester) amide [MeSH Supplementary Concept]
- 3,4-dimethoxy-trans-cinnamic acid-9-O-beta-D-allopyranoside [MeSH Supplementary Concept]
- 3,4-dimethoxycinnamyl 9-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 3,5-dihydroxycinnamic acid [MeSH Supplementary Concept]
- 3,5-dimethoxycinnamic acid [MeSH Supplementary Concept]
- 3,7-dimethyl-1,6-octadien-3-yl cinnamtae [MeSH Supplementary Concept]
- 3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid [MeSH Supplementary Concept]
- 3-(3,4-dimethoxyphenyl)propenoic acid [MeSH Supplementary Concept]
- 3-(3-(quinolin-2-ylamino)phenyl)acrylic acid [MeSH Supplementary Concept]
- 3-(3-(quinoxalin-3-ylamino)phenyl)acrylic acid [MeSH Supplementary Concept]
- 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid [MeSH Supplementary Concept]
- 3-(4-((7-hydroxy-2-oxo-3-phenyl-2H-chromen-4-yl)-methyl)phenyl)acrylic acid [MeSH Supplementary Concept]
- 3-(4-(1,2-diphenylbut-1-enyl)phenyl)acrylic acid [MeSH Supplementary Concept]
- 3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid [MeSH Supplementary Concept]
- 3-(4-(5-(4-(2-dihexylcarbamoylvinyl)phenyl)-1H-imidazol-4-yl)phenyl)acrylic acid [MeSH Supplementary Concept]
- 3-(4-chlorophenyl)-N-(7-hydroxy-6-methoxy-2-oxo-2H-chromen-3-yl)acrylamide [MeSH Supplementary Concept]
- 3-(4-methoxyphenyl)-2-propenoic acid 3-methylbutyl ester [MeSH Supplementary Concept]
- 3-(cinnamoyloxy)-19-hydroxy-urs-12-ene [MeSH Supplementary Concept]
- 3-(trifluoromethyl)cinnamide [MeSH Supplementary Concept]
- 3-O-methylrosmarinic acid [MeSH Supplementary Concept]
- 3-bromocinnamamide [MeSH Supplementary Concept]
- 3-bromocinnamic acid [MeSH Supplementary Concept]
- 3-cinnamoyltribuloside [MeSH Supplementary Concept]
- 3-fluorocinnamic acid [MeSH Supplementary Concept]
- 3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine [MeSH Supplementary Concept]
- 3-phenylpropyl cinnamate [MeSH Supplementary Concept]
- 3alpha,6beta-dicinnamoyloxytropane [MeSH Supplementary Concept]
- 4-(1-ethyl-4-anisyl-imidazol-5-yl)-N-hydroxycinnamide [MeSH Supplementary Concept]
- 4-(2-(N-(3-pyridylmethyl)carbamoylethenyl)phenoxy)acetate [MeSH Supplementary Concept]
- 4-(3'-(1-adamantyl)-4'-hydroxyphenyl)-3-(3'-acetamidopropyloxy)cinnamic acid [MeSH Supplementary Concept]
- 4-(3,3-dimethyl-1-triazeno)cinnamic acid [MeSH Supplementary Concept]
- 4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid [MeSH Supplementary Concept]
- 4-(3-(3-chloro-4-fluorophenyl)acryloyl)-1-(3-(4-hydroxy-6-azaspiro(2.5)oct-6-yl)propyl)-3-methylpiperazin-2-one [MeSH Supplementary Concept]
- 4-(dimethylamino)cinnamic acid [MeSH Supplementary Concept]
- 4-O-(4-methoxycinnamoyl) rhamnopyranoside [MeSH Supplementary Concept]
- 4-O-(beta-D-glucopyranosyl-(1- 3)-alpha-L-rhamnopyranosyl)phenylethylcinnamamide [MeSH Supplementary Concept]
- 4-O-glucopyranosyloxy-7-hydroxycinnamic acid [MeSH Supplementary Concept]
- 4-O-glucopyranosyloxy-8-hydroxycinnamic acid [MeSH Supplementary Concept]
- 4-amidinophenyl 2-methylcinnamate [MeSH Supplementary Concept]
- 4-amidinophenyl cinnamate [MeSH Supplementary Concept]
- 4-amino-2-ethoxy-cinnamic acid [MeSH Supplementary Concept]
- 4-amylcinnamoylanthranilic acid [MeSH Supplementary Concept]
- 4-chloro-alpha-cyanocinnamic acid [MeSH Supplementary Concept]
- 4-dimethylaminocinnamaldehyde [MeSH Supplementary Concept]
- 4-fluorocinnamic acid [MeSH Supplementary Concept]
- 4-hydroxy-3-methoxycinnamylpiperidine [MeSH Supplementary Concept]
- 4-hydroxy-7-((((5-hydroxy-6-((4-cinnamylphenyl)azo)-7-sulfo-2-naphthalenyl)amino)carbonyl)amino)-3-((4-cinnamylphenyl))azo-2-naphthalenesulfonic acid [MeSH Supplementary Concept]
- 4-hydroxycinnamic acid (l-phenylalanine methyl ester) amide [MeSH Supplementary Concept]
- 4-hydroxypyramidatine [MeSH Supplementary Concept]
- 4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)cinnamoylamide [MeSH Supplementary Concept]
- 4-methoxy cinnamic acid [MeSH Supplementary Concept]
- 4-methoxycinnamate methyl ester [MeSH Supplementary Concept]
- 4-methoxycinnamic acid [MeSH Supplementary Concept]
- 4-methoxymagnaldehyde B [MeSH Supplementary Concept]
- 4-phenyl-5-(4-nitrocinnamoyl)-1,3,4-thiadiazolium-2-phenylamine [MeSH Supplementary Concept]
- 4-phenyl-alpha-cyanocinnamic acid amide [MeSH Supplementary Concept]
- 5,5-diferulic acid [MeSH Supplementary Concept]
- 5,8-dihydroxy-2-(1'-cinnamoyloxy-4'-methylpent-3'-enyl)-1,4-naphthoquinone [MeSH Supplementary Concept]
- 5-(2-(methyl(2-phenethyl)amino)-2-oxoethyl)-2-(benzyloxy)cinnamic acid [MeSH Supplementary Concept]
- 5-(4-(3-phenyl-2-propenoyloxy)phenyl)-3H-(1,2)dithiole-3-thione [MeSH Supplementary Concept]
- 6-O-(2'', 4''-diacetyl-3'' -O-p-methoxycinnamoyl)-rhamnopyranosyl catalpol [MeSH Supplementary Concept]
- 6-O-(3',4'-dihydroxy-2'-methylenbutyryl)-1-O-trans-cinnamoyl-beta-D-glucopyranose [MeSH Supplementary Concept]
- 6-cinnamoyl-2H-benzo(b)(1,4)oxazin-3(4H)-one [MeSH Supplementary Concept]
- 6beta-O-2',3'-dihydrocinnamoyl-12-hydroxy-(13)15-en-16,12-olide-18-cassaneoic acid [MeSH Supplementary Concept]
- 6beta-O-cinnamoyl-12-hydroxy-(13)15-en-16,12-olide-18-cassaneoic acid [MeSH Supplementary Concept]
- 7-O-trans-cinnamoyl-6beta-hydroxyloganin [MeSH Supplementary Concept]
- 8,5-diferulic acid [MeSH Supplementary Concept]
- 8-(4-fluorophenyl)-2-(3-phenyl-2-propenoyl)-1,2,3,4-tetrahydropyrazolo(5,1-c)(1,2,4)triazine [MeSH Supplementary Concept]
- 8-(p-CF3-cinnamyl)-adenosine [MeSH Supplementary Concept]
- 8-O-4-diferulic acid [MeSH Supplementary Concept]
- 8-O-cinnamoylneoline [MeSH Supplementary Concept]
- 9,13-diacetoxy-5-cinnamoyloxy-11(15-1)-abeo-taxa-4(20),11-diene-10,15-diol [MeSH Supplementary Concept]
- 9-O-(3-O-acetyl-beta-D-glucopyranosyl)-4-hydroxycinnamic acid [MeSH Supplementary Concept]
- A 25794 [MeSH Supplementary Concept]
- ABS 130 [MeSH Supplementary Concept]
- AGN 211377 [MeSH Supplementary Concept]
- AZD9496 [MeSH Supplementary Concept]
- Acne RA-1,2 [MeSH Supplementary Concept]
- BM 42304 [MeSH Supplementary Concept]
- C-2-epi-hygromycin A [MeSH Supplementary Concept]
- CE 156811 [MeSH Supplementary Concept]
- CIN-102 [MeSH Supplementary Concept]
- CKA 1303 [MeSH Supplementary Concept]
- CKA-1306 [MeSH Supplementary Concept]
- CKD 731 [MeSH Supplementary Concept]
- CKD732 [MeSH Supplementary Concept]
- CinnGEL 2Me [MeSH Supplementary Concept]
- Dolo-Adamon [MeSH Supplementary Concept]
- Drupanin [MeSH Supplementary Concept]
- FR258900 [MeSH Supplementary Concept]
- FSC 231 [MeSH Supplementary Concept]
- GW 7604 [MeSH Supplementary Concept]
- HZ1006 [MeSH Supplementary Concept]
- LQM706 [MeSH Supplementary Concept]
- LSN862 [MeSH Supplementary Concept]
- N,N-dimethylhydrocinnamide [MeSH Supplementary Concept]
- N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide [MeSH Supplementary Concept]
- N-(2,2,2-trichloro-1-(4-(4-chlorophenyl)thiazol-2-ylamino)ethyl)cinnamamide [MeSH Supplementary Concept]
- N-(2-(hydroxyphenyl)ethyl)-4-chlorocinnamide [MeSH Supplementary Concept]
- N-(3',4',5'-trihydroxyl)-phenylethyl-4-hydroxyl-cinnamamide [MeSH Supplementary Concept]
- N-(3',4',5'-trihydroxyl)-phenylethyl-4-methoxy-cinnamamide [MeSH Supplementary Concept]
- N-(3'-hydroxyl-4'-methoxy)-phenylethyl-4-hydroxyl-cinnamamide [MeSH Supplementary Concept]
- N-(3,4-methylenedioxycinnamoyl)dopamine [MeSH Supplementary Concept]
- N-(3-methoxyphenyl)-4-chlorocinnamanilide [MeSH Supplementary Concept]
- N-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)-3-(3,4,5-trimethoxyphenyl)acrylamide [MeSH Supplementary Concept]
- N-(4-methoxycinnamoyl)glycine [MeSH Supplementary Concept]
- N-(4-trifluoromethylphenyl) 3,4-dimethoxycinnamamide [MeSH Supplementary Concept]
- N-2-(1-Cinnamylbenzene ester)-2,4-dihydroxythiobenzamide [MeSH Supplementary Concept]
- N-2-hydroxy-2-(4-hydroxyphenylethyl) 4-coumaramide [MeSH Supplementary Concept]
- N-benzyl-2'-iodo-4'-methyl-2-phenylcinnamanilide [MeSH Supplementary Concept]
- N-benzyl-2'-iodocinnamanilide [MeSH Supplementary Concept]
- N-benzylcinnamide [MeSH Supplementary Concept]
- N-cinnamoyl-1-acetoxymethyl-2-amino-1-hydroxycyclohexx-5-en-4-one [MeSH Supplementary Concept]
- N-cinnamoyl-2-amino-4-hydroxy-7-oxo-2,3,8,9-tetrahydrobenzofuran [MeSH Supplementary Concept]
- N-cinnamoyl-5,6-dehydro-4,7-dihydroxyindolidin-2-one [MeSH Supplementary Concept]
- N-cinnamoyl-5,6-dehydro-4-hydroxyindolidin-2,7-dione [MeSH Supplementary Concept]
- N-cinnamoyl-5,6-dehydro-4-hydroxyindolidin-7-one [MeSH Supplementary Concept]
- N-cinnamoyl-L-proline [MeSH Supplementary Concept]
- N-cinnamoyltyramine [MeSH Supplementary Concept]
- N-hydroxy-N-methyl-3-(2-(methylthio)phenyl)-2-propenamide [MeSH Supplementary Concept]
- N-methyl-N-styrylcinnamamide [MeSH Supplementary Concept]
- NP 25301 [MeSH Supplementary Concept]
- NSC 13778 [MeSH Supplementary Concept]
- O-(alpha-(benzoylamino)-4-(phenylazo)cinnamoyl)-beta-phenyllactate [MeSH Supplementary Concept]
- O-(alpha-(benzoylamino)cinnamoyl)-beta phenyllactate [MeSH Supplementary Concept]
- ONO 8713 [MeSH Supplementary Concept]
- PS315 [MeSH Supplementary Concept]
- S 8932 [MeSH Supplementary Concept]
- SA9000 [MeSH Supplementary Concept]
- SANT-4 compound [MeSH Supplementary Concept]
- SC 1001A [MeSH Supplementary Concept]
- SLUPP-225 [MeSH Supplementary Concept]
- SLUPP-417 [MeSH Supplementary Concept]
- SQ 10624 [MeSH Supplementary Concept]
- ST 638 [MeSH Supplementary Concept]
- SU 1498 [MeSH Supplementary Concept]
- TA 270 [MeSH Supplementary Concept]
- TG4-155 [MeSH Supplementary Concept]
- TH-39 thiazole compound [MeSH Supplementary Concept]
- YM 47522 [MeSH Supplementary Concept]
- adamon [MeSH Supplementary Concept]
- aegelinoside A [MeSH Supplementary Concept]
- aegelinoside B [MeSH Supplementary Concept]
- alpha-cyanocinnamate [MeSH Supplementary Concept]
- alpha-methyl-2-hydroxy-4-diethylaminocinnamic acid [MeSH Supplementary Concept]
- alpha-phenylcinnamate [MeSH Supplementary Concept]
- aminocinnamonitrile [MeSH Supplementary Concept]
- androprostamine A [MeSH Supplementary Concept]
- androprostamine B [MeSH Supplementary Concept]
- anhydromarmeline [MeSH Supplementary Concept]
- animacroxam [MeSH Supplementary Concept]
- antithiamine factor [MeSH Supplementary Concept]
- aphyllin [MeSH Supplementary Concept]
- asarumin C [MeSH Supplementary Concept]
- atratumycin [MeSH Supplementary Concept]
- avenanthramide B [MeSH Supplementary Concept]
- benzyl cinnamate [MeSH Supplementary Concept]
- bornyl (3,4,5-trihydroxy)-cinnamate [MeSH Supplementary Concept]
- bornyl cinnamate [MeSH Supplementary Concept]
- butyl-3,5-dimethoxy-4-hydroxycinnamate [MeSH Supplementary Concept]
- calebin-A [MeSH Supplementary Concept]
- caracasanamide [MeSH Supplementary Concept]
- carboxycinnamic acid bishydroxamide [MeSH Supplementary Concept]
- cimiracemate A [MeSH Supplementary Concept]
- cinametic acid [MeSH Supplementary Concept]
- cinnamamide [MeSH Supplementary Concept]
- cinnamic acid [MeSH Supplementary Concept]
- cinnamic aldehyde cyclic D-galactitol 3'R,4'S-acetal [MeSH Supplementary Concept]
- cinnamic anhydride [MeSH Supplementary Concept]
- cinnamoyl chloride [MeSH Supplementary Concept]
- cinnamoylphenazine [MeSH Supplementary Concept]
- cinnamyl 2-(4-isobutylphenyl)propanoate [MeSH Supplementary Concept]
- cinnamyl acetate [MeSH Supplementary Concept]
- cinnamyl benzoate [MeSH Supplementary Concept]
- cinnamyl formate [MeSH Supplementary Concept]
- cinnamyl isobutyrate [MeSH Supplementary Concept]
- cinnamyl isovalerate [MeSH Supplementary Concept]
- cinnamyl propionate [MeSH Supplementary Concept]
- cinnamyl tiglate [MeSH Supplementary Concept]
- cinnamyltrimethylsilane [MeSH Supplementary Concept]
- cinoxate [MeSH Supplementary Concept]
- cinromide [MeSH Supplementary Concept]
- cis-3-hexenyl cinnamate [MeSH Supplementary Concept]
- clerodendiod A [MeSH Supplementary Concept]
- clerodendiod B [MeSH Supplementary Concept]
- clocinnamox [MeSH Supplementary Concept]
- coniferin [MeSH Supplementary Concept]
- curcamide [MeSH Supplementary Concept]
- cyclamen aldehyde [MeSH Supplementary Concept]
- cyclamen aldehyde methyl anthranilate [MeSH Supplementary Concept]
- cynarine [MeSH Supplementary Concept]
- dalparvinene B [MeSH Supplementary Concept]
- di-(2-ethylhexyl) 2,4,5-trimethoxybenzalmalonate [MeSH Supplementary Concept]
- diacetylcymarol [MeSH Supplementary Concept]
- dimethyl (1-methyl-1,3-benzimidazol-5-yl)aminomethylenepropanedioate [MeSH Supplementary Concept]
- dimethylaminoethyl-alpha-phenylcinnamate [MeSH Supplementary Concept]
- dipiperamide D [MeSH Supplementary Concept]
- dipiperamide E [MeSH Supplementary Concept]
- docosyl-3,4 -dihydroxy-trans-cinnamate [MeSH Supplementary Concept]
- ethyl 2,5-dihydroxycinnamate [MeSH Supplementary Concept]
- ethyl 3',4',5'-trimethoxycinnamate [MeSH Supplementary Concept]
- ethyl 3',4',5'-trimethoxythionocinnamate [MeSH Supplementary Concept]
- ethyl 4-(dimethylamino)cinnamate [MeSH Supplementary Concept]
- ethyl 4-methoxycinnamate [MeSH Supplementary Concept]
- ethyl cinnamate [MeSH Supplementary Concept]
- ethyl trans-3,4-dihydroxycinnamate [MeSH Supplementary Concept]
- ethylhexyl methoxycinnamate [MeSH Supplementary Concept]
- fagaramide [MeSH Supplementary Concept]
- gagaminine [MeSH Supplementary Concept]
- geranyl cinnamate [MeSH Supplementary Concept]
- hordatine M [MeSH Supplementary Concept]
- hydropiperoside [MeSH Supplementary Concept]
- hydroxycinnamoyl caged Leu-Leu-OMe [MeSH Supplementary Concept]
- hygromycin A [MeSH Supplementary Concept]
- iferanserin [MeSH Supplementary Concept]
- igmesine [MeSH Supplementary Concept]
- indigoferic acid [MeSH Supplementary Concept]
- isoamyl cinnamate [MeSH Supplementary Concept]
- isobutyl cinnamate [MeSH Supplementary Concept]
- isoferulic acid [MeSH Supplementary Concept]
- isopropyl 3,5-dimethoxy-4-hydroxycinnamate [MeSH Supplementary Concept]
- kutkin [MeSH Supplementary Concept]
- kutkoside [MeSH Supplementary Concept]
- lagotoside B [MeSH Supplementary Concept]
- lagotoside C [MeSH Supplementary Concept]
- lapathoside A [MeSH Supplementary Concept]
- lapathoside B [MeSH Supplementary Concept]
- lapathoside C [MeSH Supplementary Concept]
- lapathoside D [MeSH Supplementary Concept]
- latilagascene B [MeSH Supplementary Concept]
- linusitamarin [MeSH Supplementary Concept]
- lusutrombopag [MeSH Supplementary Concept]
- m-nitrocinnamic acid [MeSH Supplementary Concept]
- maxafil [MeSH Supplementary Concept]
- melodamide A [MeSH Supplementary Concept]
- methocinnamox [MeSH Supplementary Concept]
- methoxyhygromycin [MeSH Supplementary Concept]
- methyl 2,5-dihydroxycinnamate [MeSH Supplementary Concept]
- methyl 2-(formamido)cinnamate [MeSH Supplementary Concept]
- methyl 3-phenyl-2,3-epoxypropanoate [MeSH Supplementary Concept]
- methyl 4-(dimethylamino)cinnamate [MeSH Supplementary Concept]
- methyl beta-methylthio-alpha-nitrocinnamate [MeSH Supplementary Concept]
- methyl cinnamate [MeSH Supplementary Concept]
- methyl-p-coumarate [MeSH Supplementary Concept]
- niruriside [MeSH Supplementary Concept]
- nonadecyl para-hydroperoxycinnamate [MeSH Supplementary Concept]
- obtusaquinone [MeSH Supplementary Concept]
- octacosyl 3',4'-dihydroxycinnamate [MeSH Supplementary Concept]
- octylmethoxycinnamate [MeSH Supplementary Concept]
- oleophytal [MeSH Supplementary Concept]
- p-formylcinnamic acid [MeSH Supplementary Concept]
- p-hydroxycinnamaldehyde [MeSH Supplementary Concept]
- paxidal [MeSH Supplementary Concept]
- pentyl cinnamate [MeSH Supplementary Concept]
- penupogenin [MeSH Supplementary Concept]
- phenethyl cinnamate [MeSH Supplementary Concept]
- physocalycoside [MeSH Supplementary Concept]
- picroside I [MeSH Supplementary Concept]
- picroside II [MeSH Supplementary Concept]
- picroside IV [MeSH Supplementary Concept]
- picroside-III [MeSH Supplementary Concept]
- poly((propyl-4-methoxycinnamate methyl)(octyl methyl))siloxane copolymer [MeSH Supplementary Concept]
- poly(allylamine-cyanocinnamylideneacetate) [MeSH Supplementary Concept]
- poly(vinylalcohol-co-vinyl-4-methoxycinnamate) [MeSH Supplementary Concept]
- polygonumins A [MeSH Supplementary Concept]
- ro 03-6037 [MeSH Supplementary Concept]
- rosmarinic acid [MeSH Supplementary Concept]
- rosmarinic acid methyl ester [MeSH Supplementary Concept]
- rosmarinic acid n-butyl ester [MeSH Supplementary Concept]
- salubrinal [MeSH Supplementary Concept]
- salvianolic acid K [MeSH Supplementary Concept]
- scroside A [MeSH Supplementary Concept]
- scroside B [MeSH Supplementary Concept]
- scroside C [MeSH Supplementary Concept]
- shade UVAGuard [MeSH Supplementary Concept]
- sibirate [MeSH Supplementary Concept]
- sinapoylglucose [MeSH Supplementary Concept]
- sodium N,N'-di(4-n-butyloxy cinnamoly)-L-cystine [MeSH Supplementary Concept]
- tert-butyl cinnamate [MeSH Supplementary Concept]
- tetrabromocinnamic acid [MeSH Supplementary Concept]
- tetracosyl-3,4 -dihydroxy-trans-cinnamate [MeSH Supplementary Concept]
- thymofolinoate A [MeSH Supplementary Concept]
- thymofolinoate B [MeSH Supplementary Concept]
- thymyl 3,4,5-trimethoxycinnamate [MeSH Supplementary Concept]
- tolibut [MeSH Supplementary Concept]
- trans-3-(2'-methylphenyl)-2-propene-1-carboxamide [MeSH Supplementary Concept]
- trans-3-hydroxyhispidin [MeSH Supplementary Concept]
- trans-4-methoxy-2-beta-D-glucopyranosyloxycinnamic acid [MeSH Supplementary Concept]
- tribulusimide C [MeSH Supplementary Concept]
- tripmycin A [MeSH Supplementary Concept]
- vanicoside A [MeSH Supplementary Concept]
- vanicoside B [MeSH Supplementary Concept]
- zosteric acid [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients